By: Karen Rowan, MyHealthNewsDaily Managing Editor
Published: 04/29/2013 06:46 PM EDT on MyHealthNewsDaily
Drugs that block estrogen may lower women's risk of breast cancer for 10 years, according to a new review of studies.
Postmenopausal women in the studies who took drugs called selective estrogen receptor modulators (SERMs), such as tamoxifen, were 38 percent less likely to develop any type of breast cancer over a 10-year period, compared with women who weren't taking SERMs. The studies also involved the SERMs raloxifene, arzoxifene and lasofoxifene.
The review shows that "each of these drugs will prevent breast cancer in populations of women," said Dr. V. Craig Jordan, scientific director of oncology at the Lombardi Comprehensive Cancer Center at Georgetown University.
The review "places into perspective the 40-year journey" of SERM research, said Jordan, whose studies in the 1970s showed that tamoxifen prevented mammary cancer in rats. He was not involved in the new study.
Only tamoxifen and raloxifene are approved by the Food and Drug Administration for the prevention of breast cancer, and only tamoxifen is approved for use in premenopausal women who are at high risk for breast cancer. The other drugs in the studies are currently being studied as treatments for osteoporosis, but they also lower the risk of breast cancer, Jordan said.
The drugs come with side effects that have made women reluctant to take them, he said. The common side effects are similar to symptoms of menopause, including hot flashes and vaginal dryness.
"There is the belief that the gains do not exceed the discomfort," Jordan said. "I think it is now time for women to seriously consider taking advantage" of the drugs' effects. Women should talk with their doctors about their options, he noted.
In the new review, researchers looked at nine studies involving more than 83,000 women. Eight of the studies compared taking a SERM with taking a placebo, while one study compared raloxifene to tamoxifen.
Researchers found that 4.2 percent of women taking a SERM developed breast cancer, while 6.3 percent of women in the control groups developed breast cancer.
The reduction in risk was primarily seen with estrogen-receptor positive breast cancers, which are fueled by estrogen, according to the study.
Jordan said that in one "pivotal" trial included in the review, researchers found that both raloxifene and tamoxifen reduced women's risk of breast cancer by 50 percent while they were taking the drugs, but only the women who took tamoxifen continued to see a reduced risk after they stopped taking the drug.
The new study also showed that only tamoxifen reduced the risk of ductal carcinoma in situ, a precancerous condition. "The other ones don't tend to do that. One of the mysteries has been why only tamoxifen really reduces DCS. "We still don't know why," Jordan said.
The more serious side but less common effects of SERMs include an increased of endometrial cancer, or cancer of the uterine lining. Among women in the studies, endometrial cancer was indeed more common in those taking SERMs, although a small number -- 168 women -- in the studies developed endometrial cancer.
The drugs also increase the risk deep-vein thrombosis.
The study did not look at whether the drugs might help women live longer. To get data on mortality rates, more time is needed, Jordan said. The drugs have not been used for long enough for an effect on mortality rates to be seen.
The study is published online Tuesday (April 30) in the journal Lancet.
Pass it on: Taking SERMs may lower women's risk of breast cancer.
- 5 Key Nutrients Women Need As They Age
- 6 Things Women Can Do to Lower Breast Cancer Risk
- 7 Cancers You Can Ward Off with Exercise
Also on HuffPost:
There Are 4 Major Classes Of Breast Cancer
Results of a massive gene analysis, published last month in the journal <em>Nature</em>, shows that there are <a href="http://www.huffingtonpost.com/2012/09/24/four-breast-cancer-types-genetics-genes_n_1909116.html">four major classes</a> of breast cancer, the Associated Press reported. "With this study, we're one giant step closer to understanding the genetic origins of the <a href="http://www.siteman.wustl.edu/ContentPage.aspx?id=6431">four major subtypes of breast cancer</a>," study researcher Matthew Ellis, M.B., B.Chir., Ph.D., of the Washington University School of Medicine and the Siteman Cancer Center, said in a statement. "Now, we can investigate which drugs work best for patients based on the genetic profiles of their tumors," he added in the statement. "For basal-like breast tumors, it's clear they are genetically more similar to ovarian tumors than to other breast cancers. Whether they can be treated the same way is an intriguing possibility that needs to be explored."
Men With Breast Cancer Fare Worse
Men are less likely to get breast cancer than women -- but when they do, it's <a href="http://www.huffingtonpost.com/2012/05/04/breast-cancer-men_n_1479739.html">often deadlier</a>, according to a study presented earlier this year at the American Society of Breast Surgeons meeting. The Associated Press reported that <a href="http://www.huffingtonpost.com/2012/05/04/breast-cancer-men_n_1479739.html">men diagnosed with breast cancer</a> live, on average, two fewer years than women who are diagnosed with breast cancer, and are also more likely to have the breast cancer spread, have larger tumors when the cancer is discovered, and be diagnosed later.
Cadmium Could Raise Breast Cancer Risk
Cadmium -- a toxic metal that can be present in foods like shellfish, root vegetables, offal and cereals -- may <a href="http://www.huffingtonpost.com/2012/03/15/cadmium-breast-cancer-intake_n_1347523.html">raise risk of breast cancer</a>, according to a March 2012 study in the journal <em>Cancer Research</em>. The research included 56,000 women. Researchers were able to analyze about how much cadmium each woman was consuming based on the cadmium-rich foods in her diet. They found that those who <a href="http://www.huffingtonpost.com/2012/03/15/cadmium-breast-cancer-intake_n_1347523.html">consumed the most cadmium</a> had a 21 percent higher breast cancer risk, compared with those who consumed the least cadmium, HuffPost's Catherine Pearson reported.
Sleep May Affect Breast Cancer Risk
Getting six or fewer hours of sleep <a href="http://www.huffingtonpost.com/2012/09/06/sleep-breast-cancer-aggressive-deprivation_n_1854658.html">may raise the risk of recurrent breast cancer</a> among post-menopausal breast cancer patients, according to a study in the journal <em>Breast Cancer Research and Treatment</em>. However, this same link was not observed for pre-menopausal breast cancer patients. The findings suggest "that <a href="http://www.uhhospitals.org/about/media-news-room/current-news/2012/08/lack-of-sleep-found-to-be-a-new-risk-factor-for-aggressive-breast-cancers">lack of sufficient sleep</a> may cause more aggressive tumors, but more research will need to be done to verify this finding and understand the causes of this association," study researcher Cheryl Thompson, Ph.D. said in the statement.
A Smallpox Virus Could Be A Promising Treatment
A <a href="http://www.eurekalert.org/pub_releases/2012-10/acos-afo092712.php">smallpox virus</a> seems to be promising against a hard-to-treat form of breast cancer, called triple-negative breast cancer, according to a study in mice presented at the 2012 Annual Clinical Congress of the American College of Surgeons. "Based upon pathology, we could see that at least 60 percent of the <a href="http://www.eurekalert.org/pub_releases/2012-10/acos-afo092712.php">tumors were completely regressed</a> and the other 40 percent had very little areas of tumor cells present with a lot of necrosis, which is a sign that the tumor was responding to therapy," study researcher Dr. Sepideh Gholami, M.D., of Stanford University Medical Center, said in a statement. ABC News pointed out that this <a href="http://abcnews.go.com/blogs/health/2012/10/01/smallpox-virus-may-help-treat-deadly-form-of-breast-cancer/">kind of breast cancer is notoriously hard to treat</a> because it doesn't respond to other hormonal or immune treatments.
Shift Work May Influence Breast Cancer Risk
Working the night shift is linked to an increased risk of breast cancer, according to two different studies that came out this year. One of them, published in the journal <em>Occupational and Environmental Medicine</em>, showed that <a href="http://www.huffingtonpost.com/2012/05/30/shift-work-breast-cancer-risk_n_1553058.html">breast cancer risk went up </a>among women who worked the night shift more than twice a week, with the risk being the highest among those who said that they are "morning people" instead of "night people." <em>The Toronto Sun</em> reported that the results of this study confirm the findings of the International Agency for Research on Cancer, which has a list of items and <a href="http://www.torontosun.com/2012/05/29/night-shift-work-linked-to-breast-cancer-risk">habits that may cause cancer</a>. The IARC considers shift work "possibly carcinogenic." The other study, published in the <em>International Journal of Cancer</em>, showed that breast cancer risk is 30 percent higher for <a href="http://www.huffingtonpost.com/2012/07/01/shift-work-breast-cancer-night-sleep_n_1612486.html">women who work the night shift</a>, with the risk being especially clear among those working night-time jobs for four years, or those who worked the night shift for three or fewer nights a week.
Breast Size May Be Linked With Breast Cancer Risk
The genes that help determine a <a href="http://www.huffingtonpost.com/2012/07/05/breast-cancer-risk-breast-size-study_n_1652292.html">woman's breast size</a> may also be linked with her breast cancer risk, according to a study published earlier this year in the journal <em>BMC Medical Genetics</em>. Researchers examined the genetic data of 16,000 women to find that seven DNA variations, called single nucleotide polymorphisms (SNPs), seem to be <a href="http://www.huffingtonpost.com/2012/07/05/breast-cancer-risk-breast-size-study_n_1652292.html">linked with breast size</a> -- and three of those SNPs are known to be associated with a person's risk of breast cancer, HuffPost's Catherine Pearson reported.
Exercise Could Help Lower Breast Cancer Risk
Just a little bit of exercise may help to <a href="http://www.huffingtonpost.com/2012/06/25/exercise-breast-cancer-risk-moderate_n_1619175.html">reduce your risk of breast cancer</a>, though the more you move, the better, according to a study in the journal <em>CANCER</em>. Researchers at the University of North Carolina in Chapel Hill found that postmenopausal or reproductive-age women in their study who exercised the most -- from 10 to 19 hours each week -- had a 30 percent <a href="http://www.huffingtonpost.com/2012/06/25/exercise-breast-cancer-risk-moderate_n_1619175.html">lower risk of breast cancer</a>, though exercising less than that was still linked with some protective benefits. "The observation of a reduced risk of breast cancer for women who <a href="http://www.eurekalert.org/pub_releases/2012-06/w-eem062012.php">engaged in exercise after menopause</a> is particularly encouraging given the late age of onset for breast cancer," study researcher Lauren McCullough said in a statement.
Type 2 Diabetes May Raise Breast Cancer Risk (For Some Women)
For post-menopausal women, <a href="http://www.telegraph.co.uk/health/healthnews/9541796/Breast-cancer-risk-raised-by-Type-2-diabetes.html">having Type 2 diabetes</a> may raise the risk of breast cancer, according to a review conducted by the International Prevention Research Institute. "On the one hand, it's thought that being overweight, often <a href="http://www.telegraph.co.uk/health/healthnews/9541796/Breast-cancer-risk-raised-by-Type-2-diabetes.html">associated with Type 2 diabetes</a>, and the effect this has on hormone activity may be partly responsible for the processes that lead to cancer growth," study researcher Peter Boyle, the president of the International Prevention Research Institute, told <em>The Telegraph</em>. "But it's also impossible to rule out that some factors related to diabetes may be involved in the process."
Being Overweight Tied To Worst Breast Cancer Outcomes
Being overweight could lead to worse outcomes from breast cancer, according to a study published August in the journal <em>Cancer</em>. Specifically, the study showed that overweight women who have been treated for breast cancer have a <a href="http://www.msnbc.msn.com/id/48800019/ns/health-cancer/t/being-overweight-tied-breast-cancer-return-death/#.UGxtN_mfGPI">higher risk of recurrence and death</a>, NBC News reported. "Obesity seemed to carry a <a href="http://www.msnbc.msn.com/id/48800019/ns/health-cancer/t/being-overweight-tied-breast-cancer-return-death/#.UGxtN_mfGPI">higher risk of breast cancer</a> recurrence and death -- even in women who were healthy at the time that they were diagnosed, and despite the fact that they received the best available chemotherapy and hormone therapy," study researcher Dr. Joseph Sparano, associate chairman of medical oncology at the Montefiore Einstein Center for Cancer Care, told NBC News.
Breast Cancer Stages and What They Mean
Marisa Weiss, MD, of breast cancer.org, explains the different breast cancer stages and what they mean.